amlitelimab IV (SAR445229) - Sanofi
rademikibart (CBP-201) - Suzhou Connect Biopharma
Spevigo (spesolimab-sbzo) - Boehringer Ingelheim, LEO Pharma
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/41346302
 
Jinping Zhang; Linlin Fu; Wenting Cai; Yan Wu; Yao Yao
 
Dec 5, 2025
 
Next